article_metadata: Federica Giannotti Carmen De Ramon Ortiz Federico Simonetta Sarah Morin Chiara Bernardi Stavroula Masouridi-Levrat Yves Chalandon Anne-Claire Mamez
article_metadata: 10.3389/fimmu.2024.1360275
article_metadata: Front Immunol
article_metadata: 2024 Mar 6:15:1360275.
article_metadata: dli hodgkin lymphoma brentuximab-vedotin haploidentical allogeneic stem cell transplant pembrolizumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/38510239/
article_metadata: Antibodies, Monoclonal, Humanized Graft vs Host Disease / drug therapy Graft vs Host Disease / etiology Hematopoietic Stem Cell Transplantation / adverse effects Hodgkin Disease / drug therapy
article_metadata: Antibodies, Monoclonal, Humanized Graft vs Host Disease / drug therapy Graft vs Host Disease / etiology Hematopoietic Stem Cell Transplantation / adverse effects Hodgkin Disease / drug therapy Case Reports Brentuximab Vedotin / therapeutic use Humans Neoplasm Recurrence, Local / drug therapy Programmed Cell Death 1 Receptor Brentuximab Vedotin pembrolizumab Programmed Cell Death 1 Receptor Antibodies, Monoclonal, Humanized
article_metadata: PMC10950903
article_metadata: 38510239
article_metadata: Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report
article_metadata: 2024